Indications for antimicrobial prescribing in European nursing homes: results from a point prevalence survey
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F12%3A10125696" target="_blank" >RIV/00179906:_____/12:10125696 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11160/12:10125696
Result on the web
<a href="http://onlinelibrary.wiley.com/doi/10.1002/pds.3196/pdf" target="_blank" >http://onlinelibrary.wiley.com/doi/10.1002/pds.3196/pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/pds.3196" target="_blank" >10.1002/pds.3196</a>
Alternative languages
Result language
angličtina
Original language name
Indications for antimicrobial prescribing in European nursing homes: results from a point prevalence survey
Original language description
PURPOSE: In light of the emerging problem with multiresistant microorganisms in nursing homes (NHs), the European Surveillance of Antimicrobial Consumption NH subproject was set up to measure and describe antimicrobial use across Europe. The aim of thispaper was to investigate the indications for antimicrobial use and hence identify targets for quality improvement. METHODS: Data were obtained from a point prevalence survey conducted in 323 NHs across 21 European countries. A resident questionnaire hadto be completed for each resident receiving an antimicrobial, collecting data such as compound name and indication for antimicrobial prescribing. Four main indications for antimicrobial use were recorded: nasal decolonisation of methicillin-resistant Staphylococcus aureus (MRSA) carriage with mupirocin, prophylactic, empirical, and microbiologically documented treatments. The latter three treatment types were further subdivided according to the targeted infections. RESULTS: In total, 196
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Pharmacoepidemiology and Drug Safety
ISSN
1053-8569
e-ISSN
—
Volume of the periodical
21
Issue of the periodical within the volume
9
Country of publishing house
US - UNITED STATES
Number of pages
8
Pages from-to
937-944
UT code for WoS article
000308295000004
EID of the result in the Scopus database
—